A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray Multiple Myeloma, a challenging and often incurable malignancy of the plasma cells, has long posed significant treatment challenges. As the Multiple Myeloma Treatment Market evolves, recent advancements are reshaping the therapeutic landscape. Among the most promising developments are bispecific antibodies, which are...